Answers are grounded in this paper and cite their sources.
The inability to identify the molecular causes of disease has led to a disappointing rate of development of new medicines. By combining the power of community-based modeling with broad access to large datasets on a platform that promotes reproducible analyses, we can work toward more predictive molecular maps that can deliver better therapeutics.
No takes yet. Share an insight, caveat, or question.
Derry et al. (2012) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: